πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

AXIM Biotechnologies Patents

Full USPTO pharma patent portfolio for AXIM Biotechnologies β€” grant dates, expiration, and drug cross-links.

Patents
138
Expiring ≀24m
3

Quick answer

AXIM Biotechnologies has 138 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months β€” use filters for patent-cliff planning.

Page 3 of 3

  1. US 8586317

    Methods of diagnosing hypophosphatemic disorders

    Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8455435

    Remedies for ischemia

    Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8425492

    In vivo device, system and usage thereof

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8277798

    Use of cells containing a specific DNA molecule as cytopathic agents to inhibit the proliferation of cells

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8236777

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8207116

    Remedies for ischemia

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8207133

    Peptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SGLT1

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8187605

    Means for the inhibition of anti-Ξ²1-adrenergic receptor antibodies

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8173673

    Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7947810

    Kits for diagnosing a hypophosphatemic disorder

    Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7928057

    Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7815921

    Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7786080

    Mutein of a bone morphogenetic protein and use thereof

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7745406

    Fibroblast growth factor (FGF23) polypeptides

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7563920

    Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate

    Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7314618

    Antibodies to fibroblast growth factor (FGF23)

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7314956

    Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell

    Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7223563

    Fibroblast growth factor (FGF23) nucleic acids

    Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 6893633

    Methods and compositions for promoting the maturation of monocytes

    Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6821510

    Methods and compositions for promoting the maturation of monocytes

    Expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6809191

    GM-CSF nucleic acid sequences

    Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6790440

    Methods and compositions for promoting the maturation of monocytes

    Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6730692

    Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

    Expires Mon Apr 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6623721

    Bifunctional chelating compounds containing hydroxamic acid residues

    Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6613788

    Elevation of circulating blood histamine levels

    Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6531120

    Ophthalmic histamine compositions and uses thereof

    Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6515003

    Heterocyclic derivatives for the treatment of diabetes and other diseases

    Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6498181

    Synergistic tumorcidal response induced by histamine

    Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6462067

    Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

    Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6407133

    Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

    Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6375946

    Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

    Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6350785

    Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

    Expires Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6305380

    Method for treatment of cancer and infectious disease

    Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6270781

    Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

    Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6245563

    Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor

    Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6242473

    Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

    Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6221893

    Administration of histamine for therapeutic purposes

    Expires Mon Apr 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6155266

    Method for treatment of cancer and infectious disease

    Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6080395

    Method and composition for topical treatment of damaged tissue using histamine as active ingredient

    Expires Mon Jun 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6071942

    Elevation of circulating blood histamine levels

    Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6071509

    Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

    Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6063373

    Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

    Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does AXIM Biotechnologies have?

138 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do AXIM Biotechnologies patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.